Investor Overview
"We believe in a digitally empowered future for clinicians and researchers, with live microscopic imaging playing an important role in establishing a new standard of precision healthcare. We believe our patent-protected technology will help clinicians make immediate informed decisions that improve patient outcomes and provide economic efficiencies within health systems."
Optiscan is a global medical technology company leading the transformation of digital pathology and precision surgery.
Optiscan is a commercial-stage company with significant opportunities in the global digital health market, including digital pathology, precision surgery, and robotic-assisted surgery. Our cutting-edge solutions address a growing demand for advanced imaging technologies, offering substantial market potential. Collaborations with top-ranked leading institutions highlight our innovative approach and commitment to revolutionizing medical imaging.
Our patented miniaturized digital endomicroscopes provide real-time, high-resolution imaging, over 1000x greater than traditional CT and MRI, through a revolutionary "tissue contact" method. This technology supports live, non-destructive 3D imaging at the single-cell level, facilitating earlier disease detection and precision treatment.
Optiscan has developed cutting edge technology that delivers:
- Real-time, non-invasive, point-of-care microscopic imaging
- Biopsy-free, slide-free, non-destructive, live imaging
- Single-cell imaging with sub-cellular resolution
- Immediate clinical feedback and decision making
- Unlimited sampling across tissue
- Collaboration between clinicians and pathologists
- A digital healthcare workflow for the 21st century
Optiscan is able to dramatically improve medical outcomes through:
- Immediate, informed clinical decisions and collaboration
- Improved patient outcomes with targeted cancer screening and surgical margin assessment
- Digital equivalent to standard histopathology
- Near perfect concordance with frozen section biopsy
- Reduction in repeat and revision surgeries
- Reduced operating times
- Reduced healthcare costs and better resource utilisation
To learn more about Optiscan technology, please visit our FAQ.
